Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Hepatitis C in the rituximab era
James M. Foran
Hematology / Oncology / Cancer Center / Breast Clinic
Research output
:
Contribution to journal
›
Comment/debate
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hepatitis C in the rituximab era'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
R-CHOP protocol
100%
Rituximab
63%
Hepatitis C
59%
Lymphoma, Large B-Cell, Diffuse
32%
Hepacivirus
27%
Multicenter Studies
25%
Risk Assessment
24%
Virus Diseases
21%